Sign in to view content

Cost-Effectiveness of Aflibercept Monotherapy vs Bevacizumab-First Followed by Switching to Aflibercept if Needed for Diabetic Macular Edema

Mathew W. MacCumber, MD, PhD

Video
Published 2023

Related

Durability of Combination Therapy of Sozinibercept, an Anti-VEGF-C/D 'Trap' With Ranibizumab in nAMD or Aflibercept in DME
Nathan C. Steinle, MD
Annual Meeting Talks
2024
Outcomes of DRCR Network Treatment Regimen Starting with Observation for Eyes With Center-involved Diabetic Macular Edema and Good Visual Acuity
Omar S. Punjabi, MD
Updates from the Field
2019
DRCR.net Anti-VEGF Comparative Effectiveness Trial for Diabetic Macular Edema
Neil M. Bressler, MD
Member Podcasts

Category: Diabetic Retinopathy

See more